TY - JOUR
T1 - Interplay of vascular endothelial growth factor receptors in organ-specific vessel maintenance
AU - Karaman, Sinem
AU - Paavonsalo, Satu
AU - Heinolainen, Krista
AU - Lackman, Madeleine H.
AU - Ranta, Amanda
AU - Hemanthakumar, Karthik A.
AU - Kubota, Yoshiaki
AU - Alitalo, Kari
N1 - Funding Information:
This work was supported by the Jenny and Antti Wihuri Foundation, the Academy of Finland (grants 307366, 314498, and 335721), the Finnish Brain Foundation, the European Research Council under the European Union’s Horizon 2020 research and innovation program (grant agreements 743155 and 874708), the Novo Nordisk Foundation (NNF16OC0023554), the Sigrid Jusélius Foundation, and the Cancer Foundation Finland (all to K. Alitalo); the Orion Research Foundation, the Finnish Foundation for Cardiovascular Research, and the University of Helsinki (to S. Karaman); and the Mary and Georg C. Ehrnrooth Foundation (to S. Paavonsalo). S. Karaman was supported by grants from the Swiss National Science Foundation (Advanced Postdoc.Mobility grant P300PB_164732), the Maud Kuistila Memorial Foundation, and the Academy of Finland (grant 330053). S. Paavonsalo was supported by the the Instrumentarium Foundation, the Mary and Georg C. Ehrnrooth Foundation, the Onni and Hilja Tuovinen Foundation, the Emil Aaltonen Foundation, and the Waldemar von Frenckell Foundation. K. Heinolainen was supported by the Ida Montini Foundation, the Biomedicum Helsinki Foundation, the K. Albin Johansson Foundation, and the Maud Kuistila Memorial Foundation. M.H. Lackman was supported by the Nylands Nation, the University of Helsinki, and the Swedish Student Foundation.
Publisher Copyright:
© 2022 Karaman et al.
PY - 2022/3/7
Y1 - 2022/3/7
N2 - Vascular endothelial growth factors (VEGFs) and their receptors (VEGFRs) are quintessential for the development and maintenance of blood and lymphatic vessels. However, genetic interactions between the VEGFRs are poorly understood. VEGFR2 is the dominant receptor that is required for the growth and survival of the endothelium, whereas deletion of VEGFR1 or VEGFR3 was reported to induce vasculature overgrowth. Here we show that vascular regression induced by VEGFR2 deletion in postnatal and adult mice is aggravated by additional deletion of VEGFR1 or VEGFR3 in the intestine, kidney, and pancreas, but not in the liver or kidney glomeruli. In the adult mice, hepatic and intestinal vessels regressed within a few days after gene deletion, whereas vessels in skin and retina remained stable for at least four weeks. Our results show changes in endothelial transcriptomes and organ-specific vessel maintenance mechanisms that are dependent on VEGFR signaling pathways and reveal previously unknown functions of VEGFR1 and VEGFR3 in endothelial cells.
AB - Vascular endothelial growth factors (VEGFs) and their receptors (VEGFRs) are quintessential for the development and maintenance of blood and lymphatic vessels. However, genetic interactions between the VEGFRs are poorly understood. VEGFR2 is the dominant receptor that is required for the growth and survival of the endothelium, whereas deletion of VEGFR1 or VEGFR3 was reported to induce vasculature overgrowth. Here we show that vascular regression induced by VEGFR2 deletion in postnatal and adult mice is aggravated by additional deletion of VEGFR1 or VEGFR3 in the intestine, kidney, and pancreas, but not in the liver or kidney glomeruli. In the adult mice, hepatic and intestinal vessels regressed within a few days after gene deletion, whereas vessels in skin and retina remained stable for at least four weeks. Our results show changes in endothelial transcriptomes and organ-specific vessel maintenance mechanisms that are dependent on VEGFR signaling pathways and reveal previously unknown functions of VEGFR1 and VEGFR3 in endothelial cells.
UR - http://www.scopus.com/inward/record.url?scp=85125004371&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85125004371&partnerID=8YFLogxK
U2 - 10.1084/jem.20210565
DO - 10.1084/jem.20210565
M3 - Article
C2 - 35050301
AN - SCOPUS:85125004371
SN - 0022-1007
VL - 219
JO - Journal of Experimental Medicine
JF - Journal of Experimental Medicine
IS - 3
M1 - e20210565
ER -